Dr. Arno James Mundt, MD

Dr. Mundt practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Mundt's NPI, 1790708808, was assigned on July 26, 2006. Dr. Mundt graduated from University Of Michigan Medical School in 1987. Dr. Mundt holds California license G87704.

Dr. Mundt's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Mundt's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Mundt is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Mundt to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mundt practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mundt's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mundt is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Mundt's licenses on file in 2 states: California and Illinois.

Dmand AI lists bladder cancer radiation, colorectal cancer radiation and prostate cancer radiation among the conditions Dr. Mundt treats.

CMS data shows 162 Medicare services from Dr. Mundt across 4 procedure codes in 2024, for 89 Medicare patients. Medicare paid $17,619 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Mundt in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 74% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mundt's median patient age at 70, with 29% women.

In 2016, Dr. Mundt wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $306 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mundt for performance year 2024, reported as part of a group. Dr. Mundt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mundt as offering telehealth.

Dmand AI links 144 papers to Dr. Mundt, published from 2006 to 2023. 2021 was the busiest year, with 7. The most frequent topics are Radiotherapy Dosage, Uterine Cervical Neoplasms and Brachytherapy. Dr. Mundt has published most often in Int J Radiat Oncol Biol Phys. Dr. Mundt's most frequent co-authors are Steven E. Waggoner, MD, Loren K. Mell, MD and James Don Murphy, MD.

Dmand AI links Dr. Mundt to 2 clinical trials. Conditions studied include Uterine Cervical Neoplasms and Uterine Cervical Diseases. University of California, San Diego sponsors the most, 2.

CMS Open Payments shows 34 general payments to Dr. Mundt from 3 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 55% of the total. Varian Medical Systems, Inc. paid the most, $15,060.

Dmand AI lists 18 awards for Dr. Mundt, most recently Gold Medal, Career Achievement in 2017.

Dr. Mundt graduated from University Of Michigan Medical School in 1987.

Dr. Mundt is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.